BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 17210699)

  • 1. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
    Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG
    Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene.
    Devereux TR; Horikawa I; Anna CH; Annab LA; Afshari CA; Barrett JC
    Cancer Res; 1999 Dec; 59(24):6087-90. PubMed ID: 10626795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
    Atkinson SP; Hoare SF; Glasspool RM; Keith WN
    Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer.
    Yan PS; Shi H; Rahmatpanah F; Hsiau TH; Hsiau AH; Leu YW; Liu JC; Huang TH
    Cancer Res; 2003 Oct; 63(19):6178-86. PubMed ID: 14559801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines.
    Guilleret I; Benhattar J
    Biochem Biophys Res Commun; 2004 Dec; 325(3):1037-43. PubMed ID: 15541393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
    Chatagnon A; Bougel S; Perriaud L; Lachuer J; Benhattar J; Dante R
    Carcinogenesis; 2009 Jan; 30(1):28-34. PubMed ID: 18952593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
    Widschwendter A; Müller HM; Hubalek MM; Wiedemair A; Fiegl H; Goebel G; Mueller-Holzner E; Marth C; Widschwendter M
    Gynecol Oncol; 2004 May; 93(2):407-16. PubMed ID: 15099954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells.
    Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS
    Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of the human telomerase gene CpG island.
    Dessain SK; Yu H; Reddel RR; Beijersbergen RL; Weinberg RA
    Cancer Res; 2000 Feb; 60(3):537-41. PubMed ID: 10676632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation analysis of the promoter F of estrogen receptor alpha gene: effects on the level of transcription on human osteoblastic cells.
    Penolazzi L; Lambertini E; Giordano S; Sollazzo V; Traina G; del Senno L; Piva R
    J Steroid Biochem Mol Biol; 2004 Jun; 91(1-2):1-9. PubMed ID: 15261302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers.
    Kyo S; Takakura M; Fujiwara T; Inoue M
    Cancer Sci; 2008 Aug; 99(8):1528-38. PubMed ID: 18754863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomethylated CpG around the transcription start site enables TERT expression and HPV16 E6 regulates TERT methylation in cervical cancer cells.
    Jiang J; Zhao LJ; Zhao C; Zhang G; Zhao Y; Li JR; Li XP; Wei LH
    Gynecol Oncol; 2012 Mar; 124(3):534-41. PubMed ID: 22108635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on cloning of hTERT promoter and its targeting transcriptional activities in telomerase-positive lung cancer cells].
    Wang YP; Tang XJ; Chen XH; Che GW; Zhu DX; Sun ZL; Zhou QH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):497-501. PubMed ID: 16909587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
    Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S
    Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chromosome 3-encoded repressor of the human telomerase reverse transcriptase (hTERT) gene controls the state of hTERT chromatin.
    Szutorisz H; Lingner J; Cuthbert AP; Trott DA; Newbold RF; Nabholz M
    Cancer Res; 2003 Feb; 63(3):689-95. PubMed ID: 12566315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DNA methylation of human telomerase reverse transcriptase promoter region in human ameloblastoma].
    Zhong M; Yan Y; Wang J; Liu J; Li L; Gong YB
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 May; 42(5):304-7. PubMed ID: 17686286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines.
    Karius T; Schnekenburger M; Ghelfi J; Walter J; Dicato M; Diederich M
    Biochem Pharmacol; 2011 Jun; 81(11):1329-42. PubMed ID: 21453686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive histone marks are associated with active transcription from a methylated ICSBP/IRF8 gene.
    Tshuikina M; Nilsson K; Oberg F
    Gene; 2008 Mar; 410(2):259-67. PubMed ID: 18242011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vorinostat, SAHA, represses telomerase activity via epigenetic regulation of telomerase reverse transcriptase in non-small cell lung cancer cells.
    Li CT; Hsiao YM; Wu TC; Lin YW; Yeh KT; Ko JL
    J Cell Biochem; 2011 Oct; 112(10):3044-53. PubMed ID: 21678477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of hTERT promoter in hepatocellular carcinomas.
    Iliopoulos D; Satra M; Drakaki A; Poultsides GA; Tsezou A
    Int J Oncol; 2009 Feb; 34(2):391-9. PubMed ID: 19148473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.